End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
- EUR | -.--% | -.--% | -.--% |
21/04 | DMS Imaging SA Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
2023 | DMS Imaging SA Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
Business Summary
Net sales are distributed geographically as follows: Europe (61.3%), North and South America (18.4%), Asia (7.1%), Middle East (4.5%), Africa (3 .9%), Oceania (1.1%) and other (3.7%).
Sales per Business
EUR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Immunotherapy Treatments for Environmental and Food Allergies
100.0
%
| 35 | 100.0 % | 41 | 100.0 % | +15.01% |
Sales per region
EUR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Europe
61.3
%
| 24 | 67.7 % | 25 | 61.3 % | +4.19% |
North and South America
18.4
%
| 4 | 10.6 % | 7 | 18.4 % | +98.91% |
Asia
7.1
%
| 4 | 11.9 % | 3 | 7.1 % | -31.64% |
Middle East
4.5
%
| 1 | 2.7 % | 2 | 4.5 % | +92.55% |
Africa
3.9
%
| 1 | 3.5 % | 2 | 3.9 % | +27.54% |
Commonwealth of Independent States
3.7
%
| 1 | 2.5 % | 1 | 3.7 % | +65.92% |
Oceania
1.1
%
| 0 | 1.0 % | 0 | 1.1 % | +26.32% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Frank Hazevoets
CEO | Chief Executive Officer | 57 | 01/19/01 |
Béatrice de Vos
CTO | Chief Tech/Sci/R&D Officer | - | - |
Jean-Paul Ansel
CHM | Chairman | 74 | 24/22/24 |
Swan Tuffery
CTO | Chief Tech/Sci/R&D Officer | - | - |
Chief Administrative Officer | - | - | |
Vincent Bille
COO | Chief Operating Officer | - | - |
Michel Baijot
BRD | Director/Board Member | - | 01/18/01 |
Human Resources Officer | - | - | |
Martine Draguet
LAW | General Counsel | - | 01/14/01 |
Philippe Ghem
PRN | Corporate Officer/Principal | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | - | - | |
Jean-Paul Ansel
CHM | Chairman | 74 | 24/22/24 |
Frank Hazevoets
CEO | Chief Executive Officer | 57 | 01/19/01 |
Samuel Sancerni
BRD | Director/Board Member | - | - |
Philippe Degeer
BRD | Director/Board Member | 61 | - |
François Meurgey
BRD | Director/Board Member | - | 13/13/13 |
Michel Baijot
BRD | Director/Board Member | - | 01/18/01 |
Louise Armengaud
BRD | Director/Board Member | - | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 1,489,607,331 | 153,335,635 ( 10.29 %) | 0 | 10.29 % |
Company contact information
Sector
Sales per region
1st Jan change | Capi. | |
---|---|---|
-22.57% | 792.74Cr | |
+76.88% | 454.22Cr | |
+8.70% | 276.78Cr | |
-2.80% | 262.09Cr | |
-50.25% | 199Cr | |
-19.10% | 170.11Cr | |
-20.29% | 146.7Cr | |
+18.95% | 123.1Cr | |
-44.86% | 110.34Cr |
- Stock Market
- Equities
- DMSIM Stock
- 0RGO Stock
- Company ASIT biotech